Karzone S 250mg/125mg Injection
Marketer
AngiaRx Lifescience
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Karzone S 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), marketed as Karzone S, combats various bacterial infections by inhibiting microbial growth and spread. Administered only under medical supervision, this combination drug requires adherence to the prescribed schedule. Complete the entire course, even with symptom improvement, as premature cessation may reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek immediate help for allergic reactions such as rash, itching, swelling, or breathing difficulties. Inform your doctor of all other medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their physician. Alcohol consumption should be avoided due to potential increased drowsiness. While usually not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration promote faster recovery. Your physician may order lab tests to monitor the medicine's effects.
Primary Ingredients of Karzone S 250mg/125mg Injection
No text provided to rephrase.
Uses of Karzone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Karzone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Karzone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Karzone S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Karzone S 250mg/125mg Injection works:
Karzone S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thereby maximizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Karzone S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Karzone S, 250mg/125mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
The administration of Karzone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Karzone S 250mg/125mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Karzone S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The 250mg/125mg Karzone S Injection requires careful administration for individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage changes for the 250mg/125mg Karzone S Injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Karzone S 250mg/125mg Injection :
Omit a Karzone S 250mg/125mg Injection dose? Seek medical advice immediately.
Facts to Know About Karzone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobials |
3,018 People bought this recently